Your Health, We Care
Release date: 2025-04-11 10:55:02 Recommended: 45
The price of different versions of finerenone varies significantly, and it needs to be comprehensively evaluated in combination with specifications, sources and regional policies.
The price of the original drug produced by Bayer in Germany is about 179 US dollars per box (10mg*100 tablets) for export to the Japanese market
The price of the generic version of the Laotian Lucius version is about $19 per box (10mg*30 tablets). The generic version of the Bangladesh Everest version is cheaper, with a 10mg*10 tablet format only costing about $4.5.
In China, finerenone has been included in the medical insurance list, and the price of a single tablet has dropped to about $0.9. Based on the standard specification (20mg*7 tablets), the price per box is about $6.3. After the reimbursement of medical insurance, the out-of-pocket expenses of patients are further reduced, and the reimbursement ratio can reach more than 70% in some areas.
The price of the original drug in the U.S. market is relatively high, with a 10mg*30 tablet specification of about $900, and a 20mg*30 tablet of about $920. In some European countries, the price is close to China's level after medical insurance negotiations, while the price of generic drugs in Southeast Asia is generally lower than $20 per box.
Medication decisions should be made based on a combination of efficacy, safety, and economic burden.
Finerenone is indicated for patients with chronic kidney disease associated with type 2 diabetes, particularly those with albuminuria or cardiovascular risk. The initial dose should be adjusted according to the eGFR and serum potassium level, and renal function and electrolytes should be monitored regularly during treatment.
Although generic drugs are inexpensive, it is necessary to ensure that they are purchased through formal channels. For example, the Bangladesh version of Mount Everest has been approved by the local drug regulatory authority, while some unvalidated generic drugs may pose quality risks.
Chinese patients are reimbursed for most of their expenses through the Medicare Catalog, and some hospitals also offer charitable assistance programs. International patients can refer to the global patient assistance programs of multinational pharmaceutical companies, or legally purchase low-cost generic drugs.
The price system of finerenone is complex, and patients should choose a treatment plan based on their own situation under the guidance of a doctor. Medical insurance policies and the popularization of generic drugs have significantly lowered the threshold for drug use, but drug quality and individualized treatment are still the core considerations.
